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Abstract The protozoan parasite and human pathogen Enta-
moeba histolytica is protected against killing by its own lytic
e¡ector proteins. Amoebae withstand doses of amoebapores,
their pore-forming polypeptides, that readily kill human Jurkat
T cells. Moreover, the polypeptides do not bind to the amoebic
surface membrane as evidenced by using £uorescently labelled
amoebapores and confocal laser microscopy. Experiments em-
ploying liposomes as a minimalistic membrane system and the
major isoform amoebapore A revealed that the lipid composition
of amoebic membranes prevents binding of the cytolytic mole-
cule and that both the phospholipid ingredients and the high
content of cholesterol contributes to the protection of the tox-
in-producing cell.
$ 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Entamoeba histolytica is an amoeboid protozoon and the
causative agent of human amoebiasis, one of the most life-
threatening parasitic infections [1]. The amoeba is a remark-
ably potent ‘killer cell’ which destroys host tissues and lyses
almost every target cell it encounters in a contact-dependent
reaction [2]. Accumulated evidence including from experi-
ments with gene-silenced amoebae revealed that a family of
pore-forming polypeptides termed amoebapores are key com-
ponents in cytolysis and pathogenicity [3^6]. Amoebapores
permeabilize membranes of prokaryotic and eukaryotic target
cells suggesting a function as a broad spectrum e¡ector mol-
ecule [7^10]. The principle of killing other cells by secreting
proteins that permeabilize target cell membranes is wide-
spread in nature. Pore-forming toxins of bacteria, hemolytic
proteins of invertebrates, the mammalian complement system
and antimicrobial peptides of various origin are well-known
examples of e¡ector molecules acting according to this prin-
ciple. However, most often the mechanism which confers re-
sistance to the cells or epithelia that produce these lytic agents
are not well understood.
Here, we analyzed the molecular basis of resistance of
pathogenic amoebae to their membrane-active e¡ector pro-
teins by using viable amoebic trophozoites, target cells of
human origin and lipid vesicles of various composition to
monitor amoebapore-induced cell death and the selectivity
of binding of the proteins to membranes. The data provide
evidence that the distinct lipid composition of amoebic mem-
branes, particularly its high cholesterol content, contributes
signi¢cantly to the protection of amoebae against their own
granule-derived toxic products discharged upon the cytolytic
reaction towards host cells.
2. Materials and methods
2.1. Lipids
Cholesterol and soybean lipids (crude phosphatidylcholine type
II-S, azolectin) were from Sigma (Deisenhofen, Germany). 3-sn-Phos-
phatidylcholine (PC) and phosphatidylinositol (PI) from bovine liver
were purchased from Fluka (Germany). Ceramide, 3-sn-phosphatidyl-
ethanolamine (PE), 3-sn-phosphatidyl-L-serine (PS) from bovine brain
and sphingomyelin from chicken egg yolk were obtained from Avanti
Polar Lipids (Alabaster, AL, USA) or Fluka. N-Acyl-sphingosylphos-
phorylethanolamine (CAEphosphate) was from Matreya (Pleasant
Gap, PA, USA).
2.2. Cultivation and harvesting of amoebae
Trophozoites of the pathogenic E. histolytica strain HM-1:IMSS
were cultured axenically in TYI-S-33 medium containing 20 g/l trypti-
case, 10 g/l yeast extract, 10 g/l D-glucose, 2 g/l NaCl, 1 g/l K2HPO4,
0.6 g/l KH2PO4, 1 g/l cysteine, 0.2 g/l ascorbic acid, 22.8 mg/l Fe-
ammonium citrate, 3% Tween 80, 2 U/ml penicillin, 0.2 g/l strepto-
mycin, and 15% heat-inactivated bovine serum [11] in plastic tissue
culture £asks. Trophozoites from cultures in late-logarithmic phase
were harvested after being chilled on ice for 10 min, sedimented at
430Ug at 4‡C for 3 min and washed three times in ice-cold PBS-A
(4.5 mM Na2HPO4, 1.5 mM KH2PO4, 147 mM NaCl, 2.5 mM KCl,
pH 7.4, 320 mosmol/kg).
2.3. Cell culture
Human leukemic Jurkat T cells (ATCC, Rockville, MD, USA) were
grown in RPMI 1640 medium (Gibco BRL, Grand Island, NY, USA)
supplemented with 10% inactivated fetal bovine serum, 2 mM L-glu-
tamine, penicillin (100 U/ml), streptomycin sulfate (100 Wg/ml), and
amphothericin (0.25 Wg/ml). Cells were maintained at 37‡C in a hu-
midi¢ed 5% CO2 atmosphere and passaged three times a week.
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2.4. Puri¢cation of amoebapores
The puri¢cation of individual amoebapore isoforms from amoebic
extracts using a Sep-Pak cartridge and two consecutive reversed-phase
high performance liquid chromatographies (HPLC) has been de-
scribed previously [7,10,12]. Puri¢ed peptides were lyophilized and
stored at 320‡C. The protein concentration was determined photo-
metrically at 214 nm using the excitation coe⁄cients calculated from
the sequence information [13]. For the preparation of the amoebapore
A, B and C mixture, all amoebapore fractions eluting from the ¢rst
HPLC column were collected in a single tube instead of separating
them. This mixture should consist of the amoebapores A, B and C in
amounts found naturally in the amoebic granules in which the major
isoform A represent approximately 70^75% of the amoebapores. For
confocal £uorescence microscopy, the amoebapore A, B, C mixture
was labelled with activated tetramethylrhodamine (TRITC) using
FluoReporter Protein Labelling Kit (Molecular Probes Europe, Lei-
den, The Netherlands).
2.5. Determination of cellular ATP content
Jurkat cells (2U105) or amoebae (1U105) were incubated in the
presence of the indicated concentration of amoebapores in 200 Wl
bu¡er (20 mM MES, 150 mM NaCl, pH 5.5) for 15 min at 37‡C.
Cells were sedimented by centrifugation and washed in bu¡er. Cell
lysis was achieved by addition of 10 Wl of 10% Triton X-100 to the cell
pellet. Each lysate was transferred into a vial containing 190 Wl lucif-
erase reagent (CLSII, Boehringer, diluted 1:8 in ddH2O) and chemi-
luminescence was measured in a luminometer (Bioluminat LB9500;
Berthold, Wildbad, Germany). The percent of luminescence of amoe-
bapore-treated cells relative to that of untreated cells was expressed as
the cellular ATP content.
2.6. Fluorescence microscopy
Amoebae and Jurkat cells were ¢xed in 200 mM sodium cacodylate
bu¡er, pH 7.4, 4% paraformaldehyde. Aliquots were incubated with
TRITC-conjugated amoebapores (in MES bu¡er) and after three
washes in PBS air-dried on slides, embedded with Mowiol (Calbio-
chem, Bad Soden, Germany) and analyzed by confocal microscopy
using the Leica TCS NT confocal laser scanning system in combina-
tion with a Leica DMR microscope (Leica, Bensheim, Germany).
2.7. Preparation of plasma membrane and granular membrane fractions
of E. histolytica
Freshly harvested and washed amoebae were resuspended in ice-
cold 150 mM NaCl and lysed by nitrogen cavitation; after an incu-
bation under nitrogen at 28 bar for 25 min, the suspension was re-
leased dropwise. The lysate was centrifuged at 430Ug at 4‡C for 10
min, the supernatant was carefully removed and centrifuged at
27 000Ug at 4‡C for 25 min. The sediment represents a fraction en-
riched in cytoplasmic granules. The supernatant was carefully re-
moved, centrifuged again at 150 000Ug at 4‡C for 40 min. This sedi-
ment represents the plasma membrane fraction. The granule fraction
was resuspended in four volumes of 10% acetic acid and incubated
overnight at 4‡C under constant shaking. The acidic suspension was
centrifuged at 150 000Ug at 4‡C for 40 min. This sediment represents
the granular membrane fraction [14].
2.8. Extraction of lipids from E. histolytica trophozoites and membrane
fraction
Extraction of lipids was performed according to the method of
Folch et al. [15]. Brie£y, sedimented trophozoites, plasma membrane,
or granular membrane fractions of E. histolytica were treated with
chloroform/methanol 2:1 (v/v), sonicated, and sedimented at 700Ug
at 4‡C for 5 min. The supernatant was removed and 1/4 volume of
chloroform/methanol/water 8:4:3 (v/v) was added. The resulting two
phases were separated and the lower phase, containing the extracted
lipids, was concentrated to a ¢fth of the volume in a speed vacuum
concentrator and subsequently dried to completeness in an exsiccator
under vacuum overnight. The lipids fractions were stored at 320‡C
until use.
2.9. Preparation of liposomes
Liposomes were prepared from azolectin or dried amoebic lipid
extracts. Additionally, a mixture (w/w) of de¢ned phospholipids, i.e.
PC (14%), PE (35%), PS (8.5%), PI (1%), sphingomyelin (1%), and
ceramide (40.5%), was used to mimic the amoebic plasma membrane
[14]. When indicated, various amounts of cholesterol were given sup-
plementary to these mixtures prior to the preparation of the lipid
¢lms. The content of cholesterol was expressed in % of total lipids
(w/w). Lipids were dissolved in chloroform, and the solvent was
evaporated under a constant stream of nitrogen to give thin lipid ¢lms
on a glass beaker surface. Residual chloroform was removed under
vacuum overnight. The lipid ¢lms were suspended by shaking in lipo-
some bu¡er (50 mM Tris maleate, 50 mM potassium sulfate, 0.5 mM
EDTA, 0.02% sodium azide, pH 5.2) containing glass beads. The
suspended lipids were analyzed by thin layer chromatography and
the concentration of phospholipids was determined using a phospho-
rus assay [16]. In all experiments using liposomes, the phospholipid
concentration was adjusted as indicated, and in some experiments
cholesterol was added as supplement.
2.10. Association of amoebapore A with liposomes
Amoebapore A (0.5 WM; Mr = 8240), diluted in liposome bu¡er,
was incubated with various amounts of lipid vesicles in a total volume
of 100 Wl at 4‡C under constant shaking for 1 h. After the incubation
period, liposomes and liposome-associated peptides were separated
from peptides in solution by centrifugation at 24 psi (approx.
100 000Ug) for 30 min using a Beckmann airfuge centrifuge. The
supernatant was removed and analyzed for residual pore-forming ac-
tivity and for reactivity to an anti-amoebapore A antiserum in an
enzyme-linked immunosorbent assay (ELISA) assay.
2.11. Assay for pore-forming activity
Pore-forming activity of samples was determined by monitoring the
dissipation of a valinomycin-induced di¡usion potential in liposomes
as described by Loew et al. [17]. Brie£y, azolectin liposomes (40 mg/
ml, Sigma) were prepared in 50 mM K2SO4, 0.5 mM EDTA, 50 mM
Tris maleate, pH 5.2, and were diluted for the assay 1:4000 in a bu¡er
with Kþ replaced by Naþ. Addition of valinomycin (1 nM, Sigma)
resulted in a potassium di¡usion potential that was monitored by
the £uorescence quenching of 3,3P-diethylthiodicarbocyanine iodide
(1 WM; Kodak) using a £uorescence spectrophotometer (LS50B; Per-
kin-Elmer) with excitation and emission wavelengths of 620 nm and
670 nm, respectively. Pore-forming activity was measured as the initial
change of £uorescence intensity over time after adding the sample.
One unit of activity was de¢ned as a £uorescence increase to 5% of
the pre-valinomycin intensity in 1 min at 25‡C.
2.12. ELISA
The assay was performed in £at-bottom microtiter plates (Maxi-
sorb, Nunc). The wells of the plates were coated with various dilutions
of the supernatants (see Section 2.10) in 100 mM sodium carbonate
Fig. 1. ATP content of Jurkat T cells and E. histolytica trophozoites
after incubation with amoebapores. Cells were incubated in the
presence of amoebapores (2.5 WM, open bars; 5 WM, shaded bars).
After 15 min, cells were sedimented and residual cellular ATP was
determined by a luminometer using luciferase reagent. ATP content
of cells was estimated as percent of control (cells in bu¡er alone).
Experiments were done in triplicate. Error bars represent medianV
range.
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bu¡er, pH 9.5 at 4‡C for 12 h followed by blocking with 5% milk
powder in PBS at 20‡C for 30 min. Subsequently, the plates were
incubated with a rabbit antiserum to amoebapore A at a 1:100 dilu-
tion in 2.5% milk powder in PBS at 20‡C for 2 h. After three washes
with PBS containing 0.1% Tween 20, the plates were incubated with
an anti-rabbit immunoglobulin antibody^peroxidase conjugate (Dako,
Denmark) at 20‡C for 2 h, washed with PBS/Tween, and the assay
was developed using o-phenylenediamine and H2O2 as substrates. The
resulting color reaction was stopped with 2 M sulfuric acid after 2^5
min and the absorbance at 490 nm was measured with an ELISA
plate reader (Titertek Multiskan Plus/MK II; ICN Flow).
2.13. Fluorescence resonance energy transfer (FRET)
The FRET assay was performed at 37‡C and as described earlier in
more detail [8]. Brie£y, liposomes prepared from various phospholip-
ids, doubly doped with £uorescently labelled PE (N-(7-nitrobenz-2-
oxa-1,3-diazol-4-yl)-phosphatidyl ethanolamine (NBD-PE) and N-
(lissamine rhodamine B sulfonyl)-phosphatidylethanolamine (Rh-PE)
(Molecular Probes, Eugene, OR, USA)) were prepared in bu¡er (8
mM sodium citrate, 100 mM KCl, 5 mM MgCl2, pH 5.2) and ¢lled
into the cuvette (1 ml, ¢nal lipid concentration 10 WM) of a £uores-
cence spectrometer (SPEX F1T11, SPEX Instruments, Edison, NY,
USA). NBD-PE was excited at 470 nm and the NBD donor and Rh
acceptor emission was monitored at 531 nm and 593 nm, respectively.
After 50 s, amoebapore A (0.1 Wg, 0.3 Wg or 1 Wg, solubilized in 0.1%
tri£uoroacetic acid (TFA)) was added to the cuvette and the donor
and acceptor £uorescence intensity was recorded over time. Interca-
lation of the peptide into the liposomes resulted in probe dilution and
as a consequence in a lower FRET e⁄ciency: the emission intensity of
the donor increases and that of the acceptor decreases. The FRET
signal is presented as the quotient of the donor and acceptor emission
intensity (IDonor/IAcceptor). The addition of the peptide solvent (0.1%
TFA) alone did not have a measurable e¡ect on the FRET signal.
3. Results
3.1. E¡ect of amoebapores on the ATP content of target cells
Viable E. histolytica trophozoites and human Jurkat cells
were incubated in the presence of amoebapores. After 15 min,
the amount of cellular ATP was determined by the luciferase
assay. Whereas the ATP content of amoeba was not a¡ected
by amoebapores, Jurkat cells lost approximately 50% of their
ATP in the presence of 5 WM amoebapores (Fig. 1).
Fig. 2. Confocal microscopy of Jurkat T cells and E. histolytica trophozoites incubated with TRITC-labelled amoebapores. Jurkat cells (upper
panels) or amoebae (lower panels), which showed a slight auto£uorescence, were incubated with TRITC-conjugated amoebapores (total amount
30 Wg) or as a control in bu¡er alone (MES, pH 5.5). Multiple focus planes (16) were accumulated to one image to gain optimal yield of £uo-
rescence. Scale bar= 10 Wm.
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3.2. Target cell binding of amoebapores
Binding of TRITC-labelled amoebapores to target cells (hu-
man Jurkat T cells) and E. histolytica trophozoites was ana-
lyzed by confocal laser microscopy (Fig. 2). Cell £uorescence
of Jurkat cells increased markedly in the presence of labelled
amoebapores (upper panels). In contrast, an increase in £uo-
rescence, i.e. binding of £uorescently labelled amoebapores,
was not observed for amoebae. A slight auto£uorescence of
the trophozoites was detectable also in the control which is
presumably due to endocytosed culture medium (lower pan-
els).
3.3. Liposome binding of amoebapore A
To elucidate the molecular basis for the observed selectivity
of amoebapore binding, we used an arti¢cial membrane sys-
tem with de¢ned lipid compositions. In this set of experi-
ments, amoebapore A was incubated in the presence of in-
creasing amounts of various types of liposomes. After
separating liposome-associated and unbound amoebapore by
ultracentrifugation, we determined the concentration of resid-
ual amoebapore A in the supernatant (i.e. unbound amoeba-
pore) by measuring the pore-forming activity. No reduction of
activity in the supernatant was observed for amoebapore A
incubated in the presence of liposomes composed of di¡erent
E. histolytica lipid preparations (total membrane lipids, plas-
ma membrane lipids and granular membrane lipids) even in a
1000-fold excess in weight of lipid vesicles indicating that
binding to any of the amoebic membrane preparations had
not occurred (Fig. 3A).
In order to dissect further the impact of the various com-
ponents of amoebic membranes, we monitored the adsorption
of amoebapore A to phospholipid vesicles and observed par-
ticularly the in£uence of cholesterol on the binding of the
pore-forming peptide to membranes.
Amoebapore A readily binds to liposomes made of azolec-
tin from soy bean, however, the binding capability was dras-
tically reduced by adding cholesterol (Fig. 3B). The weight
excess of azolectin vesicles necessary to result in 50% binding
of amoebapore A increased from 15-fold in the absence of
cholesterol to approximately 50-, 100-, and 300-fold when
the cholesterol content in the membrane was 10%, 20%, and
30%, respectively.
To mimic to some extent the natural lipid composition of
the amoebic plasma membrane, we prepared liposomes of a
mixture of ceramide, PC, sphingomyelin, PE, PS, and PI.
Here, we determined the concentration of residual amoeba-
pore A in the supernatant (i.e. unbound amoebapore) by ELI-
SA using an amoebapore A-speci¢c antibody in addition to
measurement of the residual pore-forming activity (Fig. 3C).
The two assays gave matching results con¢rming that both
methods are suitable to monitor the binding of amoebapore
to membranes. The binding a⁄nity of amoebapore A to these
liposomes was at least an order of magnitude lower than to
vesicles from azolectin and was substantially reduced further
by addition of the high amount of cholesterol (46.5%) re-
ported for amoebic membranes [14].
3.4. Intercalation of amoebapore A into liposomes composed of
phospholipids and cholesterol
We used FRET spectroscopy as a sensitive marker for pep-
tide/membrane interaction. In this assay, we included substi-
tutes for ceramide aminoethylphosphonate (CAEP), the main
lipid component of the E. histolytica plasma membrane.
CAEP is a unique sphingolipid with an ethanolamine head-
group which is linked to ceramide via a phosphono group (O-
P-C) instead of the phosphate group (O-P-O) of ordinary
phospholipids. This particular linkage mediates resistance to
the action of phospholipases. However, it should not in£uence
the overall physicochemical parameters which are responsible
for membrane packing, £uidity, and the interaction with pore-
forming proteins such as amoebapores. As mimetics for
CAEP we investigated the interaction of amoebapore A
Fig. 3. Amoebapore A binding to lipid vesicles. After incubation of
amoebapore A with liposomes of various compositions and subse-
quent sedimentation, the concentration of the peptide in the super-
natant was determined by measuring the residual pore-forming ac-
tivity. As control, amoebapore A was incubated in the absence of
lipids. A: Lipid vesicles were prepared of trophozoite total lipids
(open circles), granular membrane lipids (open triangles), or plasma
membrane lipids (open squares). B: Lipid vesicles were prepared of
azolectin (open circles), supplemented with increasing amounts of
cholesterol (10%, ¢lled circles; 20%, ¢lled triangles; 30%, ¢lled
squares, w/w). C: Liposomes were made of a synthetic lipid mixture
mimicking the natural lipid composition of the amoebic plasma
membrane without (open circles) or supplemented with 46.5% (w/w)
of cholesterol (¢lled circles). Inset: Binding of amoebapore A as
measured in the same experiment by ELISA using speci¢c antibod-
ies. The y-axis shows the relative absorbance at 490 nm (given in %
of control) and the x-axis again the phospholipid/amoebapore A ra-
tio (w/w).
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with lipids sharing the ethanolamine headgroup (PE) or the
ceramide lipid entity with CAEP (ceramide, sphingomyelin) or
both (1/1 molar mixture of PE and ceramide). In addition we
used CAEphosphate, a sphingolipid which is identical to
CAEP except that the ethanolamine headgroup is linked via
a phosphate instead of phosphonate to ceramide.
As a matter of fact, amoebapore A (1 Wg) does not inter-
calate into any of the CAEP-mimetic membranes, i.e. ceram-
ide (not shown), sphingomyelin, PE, PE/ceramide (1/1), and
CAEphosphate (Fig. 4A). On the contrary, addition of amoe-
bapore A to liposomes prepared from negatively charged
phospholipids (PS or PG) resulted in a strong, dose-dependent
increase of the FRET signal indicating that the peptide inter-
calates into the liposome membrane even at a low peptide/
phospholipid ratio (Fig. 4B). Supplementing PG liposomes
with cholesterol leads to a dose-dependent decrease of the
FRET signal, suggesting that the sterol to some extent pre-
vents membrane insertion of the peptide (Fig. 4C).
4. Discussion
Amoebapores, the pore-forming polypeptides of E. histoly-
tica, are potent cytolytic e¡ector molecules that are stored in
and are released from cytotoxic granules. The killing of hu-
man host cells induced by amoebae takes place after cell^cell
contact has been established [18]. More relevant for the amoe-
bic life inside the colon, amoebapores act as antimicrobial
agents to combat growth of ingested bacteria, the primary
nutrient source of the amoeba, inside the digestive vacuoles
(for review see [19,20]). Structurally, amoebapores belong to
the family of saposin-like proteins, lipid-binding and mem-
brane-interacting proteins. Granulysin and NK-lysin, mem-
branolytic e¡ector peptides from mammalian cytotoxic lym-
phocytes [21,22], are functionally similar members of that
protein family. Besides this a⁄liation there are several lines
of direct experimental evidence that amoebapores act by per-
meabilizing the membranes of their targets : depolarization of
liposomes [7,9,23], oligomerization and pore formation in pla-
nar lipid membranes [8,24], in£ux of a DNA intercalating dye
into amoebapore-treated bacteria [9,10], and £uorescent dye
release from prelabelled metabolically active nucleated cells
[4,9]. Recently, we demonstrated that amoebapores binds to
the surface of phagocytosed bacteria inside the amoeba in
vivo [10] and here we show that amoebapores readily bind
to the surface of Jurkat cells.
Although the involvement of amoebapores in host cell de-
struction has been proposed decades ago and was con¢rmed
by accumulated evidence, the issue remained unresolved how
amoebae can kill several target cells within minutes coming
out of the lytic attack unharmed and what the molecular basis
is for the apparently inherent resistance of amoebae to their
cytolytic mediators. Here, we observed that a loss of cellular
ATP, a very sensitive marker of cell injury, does not occur
after incubation of viable Entamoeba trophozoites with amoe-
bapores in concentrations su⁄cient to reduce the ATP content
of Jurkat cells by 50% in the same time period.
In general, resistance of eukaryotic cells towards pore-form-
ing toxin attack may be due to various causes and has been
investigated particularly for bacterial toxins. Absence of high
a⁄nity binding sites [25], inhibition of insertion of the pore-
forming domain despite assembly of oligomers after binding
to the target cell membrane [26], and the capacity to repair
lesions in that the inserted pore is closed through constriction
[27] are those mechanisms which are exempli¢ed for various
target cells that survive the assault of Staphylococcus K-toxin.
Additional protection strategies have been reported for organ-
isms encountering membranolytic toxins. They include the de-
pendence of the sea anemone equinatoxin II on sphingomyelin
[28], immunity proteins of Gram-positive bacteria, which bind
Fig. 4. Amoebapore A intercalation into lipid vesicles as determined
by FRET spectroscopy. The peptide was added (arrow) in the indi-
cated amounts to various liposomes double-labelled with NBD-PE
and Rh-PE. A: Liposomes of sphingomyelin (SM), PE, a 1/1 molar
mixture of PE/ceramide (PE/cer), or of CAEphosphate. Please note
that in all cases no change of the FRET signal was observed. For
better visualization, each curve is presented with di¡erent o¡set, ac-
cordingly, each dash at the y-axis represents a donor/acceptor ratio
of 1.0. The axis scale is identical to B and C. B: Liposomes of PS
(dotted line) or PG (solid line). C: Liposomes of PG supplemented
with indicated amounts of cholesterol (0^30% w/w). An intercalation
of the peptide leads to an increase of the FRET signal (IDonor/
IAcceptor). Representative experiments each performed at least in du-
plicate are shown. The peptide solvent (0.1% TFA) served as a con-
trol.
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to bacteriocins and inhibit their activity [29], modi¢cations of
the protein receptor of colicin [30], and an ABC transporter,
which expels the lantibiotic epidermin from the bacterial cy-
toplasmic membrane into the surrounding medium [31].
Importantly, we failed to detect £uorescently labelled amoe-
bapores on the surface of amoebae by confocal microscopy.
This experiment indicates that the prevention of binding of
the amoebic protein to the membrane is the main mechanism
to confer protection of amoebae against their own toxins. The
preference of amoebapores for negatively charged phospholip-
ids described previously and shown also here by FRET spec-
troscopy certainly contributes to the ine⁄ciency towards
amoebic trophozoites: though the amoeba plasma membrane
also contains signi¢cant amounts (ca. 10%) of anionic phos-
pholipids (PS and PI) [14], it is likely that these lipids are
located mainly at the inner membrane lea£et as found with
other eukaryotic cells (see [32,33] and references therein) and
hence are not accessible on the cell surface. Moreover, a non-
phospholipid membrane compound appears to contribute
substantially to the protection of amoebae as cholesterol re-
duces the binding a⁄nity of amoebapore to azolectin lipo-
somes by more than two orders of magnitude and it substan-
tially reduces the intercalation of the peptide into negatively
charged PG vesicles. Whereas bacteria lack cholesterol, it is an
important component of eukaryotic cell membranes. For E.
histolytica, the plasma membrane content of cholesterol is
considerably high (46.5% per mol of phospholipids) [14].
The e¡ects of cholesterol on membrane properties are diverse.
It increases the membrane £uidity in the gel phase but essen-
tially contributes to membrane rigidity in the physiologically
relevant liquid crystalline phase by enhancing the ordering of
the fatty acid acyl chains [34] and therefore has been dubbed a
‘dynamic glue’ [35]. Accordingly, the activity of many mem-
brane-permeabilizing polypeptides, e.g. the antimicrobial pep-
tides magainin 2 and gramicidin S, is substantially decreased
when cholesterol has been introduced into arti¢cial target
membranes [36^38]. Thus it is likely, and consistent with
our data, that cholesterol also contributes to some extent to
the target selectivity of amoebapores. However, as the binding
to and intercalation into the phospholipid bilayer is signi¢-
cantly reduced but not omitted when cholesterol was intro-
duced as evidenced with liposomes composed of azolectin or
PG, the ¢nding that lipid vesicles made from natural amoebic
membranes does not bind amoebapore at all cannot be ex-
plained entirely by the high content of cholesterol. Moreover,
amoebapore binding a⁄nity to lipid vesicles that mimic to
some extent the plasma membrane of amoebic trophozoites
in its composition of commercially available phospholipids
and in its high cholesterol content was extremely low but still
detectable. This may indicate that (i) membrane asymmetry,
which is actively generated in vivo [33], is not represented in
the model system; as a consequence, signi¢cant amounts of
negatively charged lipids are presented to the liposome surface
and thus enable amoebapore A binding to these vesicles, and/
or (ii) a component not introduced into the arti¢cial system
contributes to amoebapore resistance. Interestingly, the un-
usual phosphonolipid CAEP is a major phospholipid constit-
uent of the amoebic plasma membrane [14]. CAEP is partic-
ularly known for its stability against hydrolysis and may help
to protect the amoebic membranes against several aggressive
components. Notably, the secretory, lysosome-like granules of
amoebae contain a full complement of hydrolytic enzymes in
addition to amoebapores [39^42]. Although the mode of ac-
tion of amoebapores has nothing to do with hydrolysis,
CAEP would clearly help to prevent the intercalation of
amoebapore A, as shown by FRET spectroscopy using a
very similar, but commercially available, lipid (CAEphos-
phate) or lipids mimicking either the headgroup (PE) or the
fatty acid chain (ceramide, sphingomyelin) properties of
CAEP. It is suggestive to think that the large amount of
sphingolipids (39% CAEP [14]) in the plasma membrane of
E. histolytica, which is almost twice as abundant as the sphin-
golipid content of other eukaryotic cell membranes (20^25%
sphingomyelin [33,43,44]), would, in combination with choles-
terol, result in the formation of membrane-stabilizing lipid
rafts in high density and would thereby contribute signi¢-
cantly to the self-protection of E. histolytica against amoeba-
pores.
In conclusion, a particular membrane lipid composition
that does not allow the binding of amoebapores provides a
virtually satisfactory explanation for the resistance of amoe-
bae to their own toxic proteins. The rapid and continuous
turnover of the amoebic surface membrane by endo- and
exocytotic events and the total coverage of trophozoites by
glycosylphosphatidylinositol-anchored proteophosphoglycan
molecules [45] may further contribute to protection against
lethal damage. In its natural environment, the human colon,
E. histolytica is surrounded by a variety of microorganisms
that may produce toxic components to succeed against their
competitors. The principle of possessing membranes almost
non-vulnerable to amoebapores could not only spare amoebae
from being lysed by their own e¡ector proteins but may also
provide protection against some membrane-active toxins of
other colon-dwelling microbes.
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